Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, is in an ideal position to be “profitable” in 2023. That was the outlook reported in a shareholder letter released by JUPW CEO Brian John. The letter noted 2022 highlights, such as the company becoming the second U.S. equity to dual list on Upstream, a revolutionary trading app for digital securities and NFTs, and JUPW’s SRM Entertainment division submitting a confidential registration statement to the SEC on a key step on its journey to becoming an independently traded NASDAQ company. The letter also noted that Jupiter Wellness had expanded to the Indian market with its Photofirst product and had seen its NoStingz sunscreen register record sales during the January Surf Expo in Orlando. In addition, the company reported record revenues in 2022 with plans for even more success in 2023, based on a license agreement with Taisho Pharmaceutical Co. Ltd. to sell Minoxidil Booster and Photocil in the Japanese market and Sanpellegrino Cosmetics Pvt Ltd & Cosmofix Technovation Pvt Ltd. in the Indian market and 31 other countries. The letter added that Jupiter will be developing revolutionary prescription products through an exclusive licensing agreement with Rejoy Inc. “As we look forward to 2023, the entire executive team at Jupiter Wellness is grateful for your support and commitment to our success,” wrote Jupiter Wellness CEO Brian John in the shareholder letter. “With your help, we have been able to lay the groundwork for even greater financial growth, monetization of our clinical trial programs, improvements in profitability, and an increase in shareholder value.”
To view the full press release, visit https://ibn.fm/GXcSa
About Jupiter Wellness Inc.
Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements and licensing royalties. For additional information about this company, please visit www.JupiterWellnessInc.com.
NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
InvestorWire is part of the InvestorBrandNetwork.